Literature DB >> 22890274

High-throughput fractionation of human plasma for fast enrichment of low- and high-abundance proteins.

Lucas Breen1, Lulu Cao, Kirsten Eom, Martina Srajer Gajdosik, Lila Camara, Jasminka Giacometti, Damian E Dupuy, Djuro Josic.   

Abstract

BACKGROUND: Fast, cost-effective and reproducible isolation of IgM from plasma is invaluable to the study of IgM and subsequent understanding of the human immune system. Additionally, vast amounts of information regarding human physiology and disease can be derived from analysis of the low abundance proteome of the plasma. In this study, methods were optimized for both the high-throughput isolation of IgM from human plasma, and the high-throughput isolation and fractionation of low abundance plasma proteins.
MATERIALS AND METHODS: To optimize the chromatographic isolation of IgM from human plasma, many variables were examined including chromatography resin, mobile phases, and order of chromatographic separations. Purification of IgM was achieved most successfully through isolation of immunoglobulin from human plasma using Protein A chromatography with a specific resin followed by subsequent fractionation using QA strong anion exchange chromatography. Through these optimization experiments, an additional method was established to prepare plasma for analysis of low abundance proteins. This method involved chromatographic depletion of high-abundance plasma proteins and reduction of plasma proteome complexity through further chromatographic fractionation.
RESULTS: Purification of IgM was achieved with high purity as confirmed by SDS-PAGE and IgM-specific immunoblot. Isolation and fractionation of low abundance protein was also performed successfully, as confirmed by SDS-PAGE and mass spectrometry analysis followed by label-free quantitative spectral analysis. DISCUSSION: The level of purity of the isolated IgM allows for further IgM-specific analysis of plasma samples. The developed fractionation scheme can be used for high throughput screening of human plasma in order to identify low and high abundance proteins as potential prognostic and diagnostic disease biomarkers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890274      PMCID: PMC3418625          DOI: 10.2450/2012.013S

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  16 in total

1.  Percutaneous radiofrequency ablation of malignancies in the lung.

Authors:  D E Dupuy; R J Zagoria; W Akerley; W W Mayo-Smith; P V Kavanagh; H Safran
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

Review 2.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

3.  Use of selective extraction and fast chromatographic separation combined with electrophoretic methods for mapping of membrane proteins.

Authors:  Djuro Josic; Mari Kino Brown; Feilei Huang; Helen Callanan; Marijana Rucević; Alison Nicoletti; James Clifton; Douglas C Hixson
Journal:  Electrophoresis       Date:  2005-07       Impact factor: 3.535

4.  Detection of trace proteins in multicomponent mixtures using displacement chromatography.

Authors:  Steven T Evans; Melissa Holstein; Steven M Cramer
Journal:  Anal Chem       Date:  2011-05-12       Impact factor: 6.986

5.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

Authors:  Terri A Addona; Xu Shi; Hasmik Keshishian; D R Mani; Michael Burgess; Michael A Gillette; Karl R Clauser; Dongxiao Shen; Gregory D Lewis; Laurie A Farrell; Michael A Fifer; Marc S Sabatine; Robert E Gerszten; Steven A Carr
Journal:  Nat Biotechnol       Date:  2011-06-19       Impact factor: 54.908

Review 6.  Sample displacement chromatography as a method for purification of proteins and peptides from complex mixtures.

Authors:  Martina Srajer Gajdosik; James Clifton; Djuro Josic
Journal:  J Chromatogr A       Date:  2012-03-30       Impact factor: 4.759

7.  Protease inhibitors as possible pitfalls in proteomic analyses of complex biological samples.

Authors:  James Clifton; Feilei Huang; Marijana Rucevic; Lulu Cao; Douglas Hixson; Djuro Josic
Journal:  J Proteomics       Date:  2011-02-17       Impact factor: 4.044

8.  High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.

Authors:  Maja Pucić; Ana Knezević; Jana Vidic; Barbara Adamczyk; Mislav Novokmet; Ozren Polasek; Olga Gornik; Sandra Supraha-Goreta; Mark R Wormald; Irma Redzić; Harry Campbell; Alan Wright; Nicholas D Hastie; James F Wilson; Igor Rudan; Manfred Wuhrer; Pauline M Rudd; Djuro Josić; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2011-06-08       Impact factor: 5.911

9.  SELDI-TOF as a method for biomarker discovery in the urine of aristolochic-acid-treated mice.

Authors:  Feilei Huang; James Clifton; Xinli Yang; Thomas Rosenquist; Douglas Hixson; Spomenka Kovac; Djuro Josic
Journal:  Electrophoresis       Date:  2009-04       Impact factor: 3.535

10.  A targeted proteomics-based pipeline for verification of biomarkers in plasma.

Authors:  Jeffrey R Whiteaker; Chenwei Lin; Jacob Kennedy; Liming Hou; Mary Trute; Izabela Sokal; Ping Yan; Regine M Schoenherr; Lei Zhao; Uliana J Voytovich; Karen S Kelly-Spratt; Alexei Krasnoselsky; Philip R Gafken; Jason M Hogan; Lisa A Jones; Pei Wang; Lynn Amon; Lewis A Chodosh; Peter S Nelson; Martin W McIntosh; Christopher J Kemp; Amanda G Paulovich
Journal:  Nat Biotechnol       Date:  2011-06-19       Impact factor: 54.908

View more
  2 in total

1.  Shaking hands with the future through omics application in transfusion medicine and clinical biochemistry.

Authors:  Lello Zolla; Angelo D'Alessandro
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 2.  Foodomics and Food Safety: Where We Are.

Authors:  Uroš Andjelković; Martina Šrajer Gajdošik; Dajana Gašo-Sokač; Tamara Martinović; Djuro Josić
Journal:  Food Technol Biotechnol       Date:  2017-09       Impact factor: 3.918

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.